Načítá se...
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy
Adoptive cell therapy with virus-specific T cells has been used successfully to treat life-threatening viral infections, supporting application of this approach to coronavirus disease 2019 (COVID-19). We expand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T cells from the peripheral...
Uloženo v:
| Vydáno v: | Cell Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Authors.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8260499/ https://ncbi.nlm.nih.gov/pubmed/34270918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2021.109432 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|